ClearOne, Inc. Reports Second Quarter 2024 Financial Results
- Sequential and Year-over-Year OpEx Reductions Reflect Continued Benefits of Cost Optimization Initiatives-
Revenue declined 58% sequentially and 39% year over year, primarily due to a significant decrease in revenues from the audio conferencing category, which includes our DSP mixer products. “We believe this revenue decline was primarily due to the cumulative impact of past production shortages,” said
Operational Highlights
-
The Company showcased its full line of collaboration and conferencing solutions at Infocomm 2024, including seamless integration with popular collaboration solutions from other companies and a comprehensive portfolio of solutions for various applications and meeting room sizes. The Company captured 60% more sales leads due to in-person visitors during
Infocomm USA 2024 compared toInfocomm USA 2023. - The Company introduced the Versa Lite BMA 360D in Q2 2024. This innovative bundle combines ClearOne’s industry-leading BMA 360D Dante® enabled microphone array ceiling tile with the Versa® USB22D Dante® adapter, offering a perfect audio solution for any conferencing space with an easy connection to any computer or room device via USB.
- The Company reduced operating expenses by 10.1% sequentially and 9.33% year-over-year.
Graham continued, “During the first half of 2024, our team has been diligently working to win back customers who have defected to competing brands. We believe, although there can be no assurance, those efforts will bear fruit soon. We continue to see strong interest in our innovative products as demonstrated by the 60% increase in visitors at our
Financial Summary
The Company uses certain non-GAAP financial measures and reconciles those to GAAP measures in the attached tables.
• |
|
Q2 2024 revenue was |
|
|
|
• |
|
GAAP gross profit/(loss) in Q2 2024 was |
|
|
|
• |
|
Operating expenses in Q2 2024 improved to |
|
|
|
• |
|
GAAP net loss in Q2 2024 was |
|
|
|
• |
|
Non-GAAP net loss in Q2 2024 was |
($ in 000, except per share) |
Three months ended |
Six months ended |
|||||||||||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
Change in %
|
|
|
|
|
2024 |
|
|
|
2023 |
|
|
Change in %
|
|
|
GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Revenue |
$ |
2,304 |
|
$ |
5,483 |
|
(58 |
) |
$ |
5,926 |
|
$ |
9,661 |
|
(39 |
) |
|||||||
Gross profit |
|
(20 |
) |
|
1,848 |
|
(101 |
) |
|
1,131 |
|
|
3,163 |
|
(64 |
) |
|||||||
Operating expenses |
|
2,904 |
|
|
3,203 |
|
9 |
|
|
6,133 |
|
|
6,707 |
|
9 |
|
|||||||
Operating loss |
|
(2,924 |
) |
|
(1,355 |
) |
(116 |
) |
|
(5,002 |
) |
|
(3,544 |
) |
(41 |
) |
|||||||
Net loss |
|
(2,820 |
) |
|
(1,019 |
) |
(177 |
) |
|
(4,718 |
) |
|
(1,851 |
) |
(155 |
) |
|||||||
Diluted loss per share |
|
(0.12 |
) |
|
(0.04 |
) |
(200 |
) |
|
(0.20 |
) |
|
(0.08 |
) |
(150 |
) |
|||||||
Non-GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-GAAP operating expenses |
$ |
2,830 |
$ |
3,051 |
|
7 |
$ |
5,925 |
|
$ |
6,413 |
|
8 |
|
|||||||||
Non-GAAP operating loss |
|
(2,835 |
) |
|
(1,201 |
) |
(136 |
) |
|
(4,777 |
) |
|
(3,250 |
) |
(47 |
) |
|||||||
Non-GAAP net loss |
|
(2,731 |
) |
|
(865 |
) |
(216 |
) |
|
(4,493 |
) |
|
(2,907 |
) |
(55 |
) |
|||||||
Non-GAAP Adjusted EBITDA |
|
(2,660 |
) |
|
(710 |
) |
(275 |
) |
|
(4,367 |
) |
|
(2,389 |
) |
(83 |
) |
|||||||
Non-GAAP diluted loss per share |
|
(0.11 |
) |
|
(0.04 |
) |
(175 |
) |
|
(0.19 |
) |
|
(0.12 |
) |
(55 |
) |
About
Non-GAAP Financial Measures
To supplement our consolidated financial statements presented on a GAAP basis,
Forward Looking Statements
This release contains “forward-looking” statements that are based on present circumstances and on ClearOne’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements and any statements of the plans and objectives of management for future operations and forecasts of future growth and value are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. Such forward-looking statements are made only as of the date of this release and
In particular, the financial information contained herein is subject to and qualified by reference to the financial statements contained in the 10-Q, including the footnotes thereto, as well as the Company’s annual report on Form 10-K for the year ended
|
||||||||
|
|
|
|
|
||||
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
2,450 |
|
|
$ |
17,835 |
|
Current marketable securities |
|
|
1,852 |
|
|
|
3,480 |
|
Patent cross license receivable |
|
|
— |
|
|
|
4,000 |
|
Receivables, net of allowance of |
|
|
2,574 |
|
|
|
3,279 |
|
Inventories, net |
|
|
14,599 |
|
|
|
10,625 |
|
Income tax receivable |
|
|
27 |
|
|
|
36 |
|
Prepaid expenses and other assets |
|
|
3,855 |
|
|
|
4,062 |
|
Total current assets |
|
|
25,357 |
|
|
|
43,317 |
|
Long-term marketable securities |
|
|
621 |
|
|
|
916 |
|
Long-term inventories, net |
|
|
1,772 |
|
|
|
3,143 |
|
Property and equipment, net |
|
|
552 |
|
|
|
530 |
|
Operating lease - right of use assets, net |
|
|
804 |
|
|
|
990 |
|
Intangibles, net |
|
|
1,582 |
|
|
|
1,689 |
|
Other assets |
|
|
108 |
|
|
|
109 |
|
Total assets |
|
$ |
30,796 |
|
|
$ |
50,694 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
1,901 |
|
|
$ |
1,945 |
|
Accrued liabilities |
|
|
1,726 |
|
|
|
2,290 |
|
Deferred product revenue |
|
|
23 |
|
|
|
30 |
|
Total current liabilities |
|
|
3,650 |
|
|
|
4,265 |
|
Operating lease liability, net of current |
|
|
515 |
|
|
|
665 |
|
Other long-term liabilities |
|
|
1,079 |
|
|
|
1,079 |
|
Total liabilities |
|
|
5,244 |
|
|
|
6,009 |
|
|
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
24 |
|
|
|
24 |
|
Additional paid-in capital |
|
|
31,616 |
|
|
|
46,047 |
|
Accumulated other comprehensive loss |
|
|
(294 |
) |
|
|
(310 |
) |
Accumulated deficit |
|
|
(5,794 |
) |
|
|
(1,076 |
) |
Total shareholders' equity |
|
|
25,552 |
|
|
|
44,685 |
|
Total liabilities and shareholders' equity |
|
$ |
30,796 |
|
|
$ |
50,694 |
|
|
||||||||||||||||||||
|
|
Three months ended |
|
Six months ended |
||||||||||||||||
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||||||
Revenue |
|
$ |
2,304 |
|
|
$ |
5,483 |
|
|
$ |
5,926 |
|
|
$ |
9,661 |
|
||||
Cost of goods sold |
|
|
2,324 |
|
|
|
3,635 |
|
|
|
4,795 |
|
|
|
6,498 |
|
||||
Gross profit |
|
|
(20 |
) |
|
|
1,848 |
|
|
|
1,131 |
|
|
|
3,163 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sales and marketing |
|
|
1,191 |
|
|
|
1,323 |
|
|
|
2,503 |
|
|
|
2,515 |
|
||||
Research and product development |
|
|
868 |
|
|
|
873 |
|
|
|
1,762 |
|
|
|
1,916 |
|
||||
General and administrative |
|
|
845 |
|
|
|
1,007 |
|
|
|
1,868 |
|
|
|
2,276 |
|
||||
Total operating expenses |
|
|
2,904 |
|
|
|
3,203 |
|
|
|
6,133 |
|
|
|
6,707 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Operating loss |
|
|
(2,924 |
) |
|
|
(1,355 |
) |
|
|
(5,002 |
) |
|
|
(3,544 |
) |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Interest expense |
|
|
— |
|
|
|
(91 |
) |
|
|
— |
|
|
|
(383 |
) |
||||
Other income, net |
|
|
119 |
|
|
|
437 |
|
|
|
297 |
|
|
|
2,103 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Loss before income taxes |
|
|
(2,805 |
) |
|
|
(1,009 |
) |
|
|
(4,705 |
) |
|
|
(1,824 |
) |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Provision for income taxes |
|
|
15 |
|
|
|
10 |
|
|
|
13 |
|
|
|
27 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Net loss |
|
$ |
(2,820 |
) |
|
$ |
(1,019 |
) |
|
$ |
(4,718 |
) |
|
$ |
(1,851 |
) |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic weighted average shares outstanding |
|
|
23,969,148 |
|
|
|
23,955,802 |
|
|
|
23,969,148 |
|
|
|
23,955,785 |
|
||||
Diluted weighted average shares outstanding |
|
|
23,969,148 |
|
|
|
23,955,802 |
|
|
|
23,969,148 |
|
|
|
23,955,785 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic loss per share |
|
$ |
(0.12 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.08 |
) |
||||
Diluted loss per share |
|
$ |
(0.12 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.08 |
) |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net loss |
|
$ |
(2,820 |
) |
|
$ |
(1,019 |
) |
|
$ |
(4,718 |
) |
|
$ |
(1,851 |
) |
||||
Unrealized loss on available-for-sale securities, net of tax |
|
|
(3 |
) |
|
|
14 |
|
|
|
19 |
|
|
|
14 |
|
||||
Change in foreign currency translation adjustment |
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(3 |
) |
|
|
4 |
|
||||
Comprehensive loss |
|
$ |
(2,824 |
) |
|
$ |
(1,006 |
) |
|
$ |
(4,702 |
) |
|
$ |
(1,833 |
) |
|
||||||||||||||||||||
|
|
Three months ended |
|
Six months ended |
||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
GAAP operating loss |
|
$ |
(2,924 |
) |
|
$ |
(1,355 |
) |
|
$ |
(5,002 |
) |
|
$ |
(3,544 |
) |
||||
Stock-based compensation |
|
|
39 |
|
|
|
25 |
|
|
|
65 |
|
|
|
47 |
|
||||
Amortization of intangibles |
|
|
50 |
|
|
|
129 |
|
|
|
160 |
|
|
|
247 |
|
||||
Non-GAAP operating loss |
|
$ |
(2,835 |
) |
|
$ |
(1,201 |
) |
|
$ |
(4,777 |
) |
|
$ |
(3,250 |
) |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
GAAP net loss |
|
$ |
(2,820 |
) |
|
$ |
(1,019 |
) |
|
|
(4,718 |
) |
|
|
(1,851 |
) |
||||
Stock-based compensation |
|
|
39 |
|
|
|
25 |
|
|
|
65 |
|
|
|
47 |
|
||||
Amortization of intangibles |
|
|
50 |
|
|
|
129 |
|
|
|
160 |
|
|
|
247 |
|
||||
Other income adjustment |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,350 |
) |
||||
Non-GAAP net loss |
|
$ |
(2,731 |
) |
|
$ |
(865 |
) |
|
$ |
(4,493 |
) |
|
$ |
(2,907 |
) |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
GAAP net loss |
|
$ |
(2,820 |
) |
|
$ |
(1,019 |
) |
|
$ |
(4,718 |
) |
|
$ |
(1,851 |
) |
||||
Number of shares used in computing GAAP diluted loss per share |
|
|
23,969,148 |
|
|
|
23,955,802 |
|
|
|
23,969,148 |
|
|
|
23,955,785 |
|
||||
GAAP diluted loss per share |
|
$ |
(0.12 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.08 |
) |
||||
Non-GAAP net loss |
|
$ |
(2,731 |
) |
|
$ |
(865 |
) |
|
$ |
(4,493 |
) |
|
$ |
(2,907 |
) |
||||
Number of shares used in computing Non-GAAP diluted loss per share |
|
|
23,969,148 |
|
|
|
23,955,802 |
|
|
|
23,969,148 |
|
|
|
23,955,785 |
|
||||
Non-GAAP diluted loss per share |
|
$ |
(0.11 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.19 |
) |
|
$ |
(0.12 |
) |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
GAAP net loss |
|
$ |
(2,820 |
) |
|
$ |
(1,019 |
) |
|
$ |
(4,718 |
) |
|
$ |
(1,851 |
) |
||||
Stock-based compensation |
|
|
39 |
|
|
|
25 |
|
|
|
65 |
|
|
|
47 |
|
||||
Interest expense |
|
|
— |
|
|
|
91 |
|
|
|
— |
|
|
|
383 |
|
||||
Depreciation |
|
|
56 |
|
|
|
54 |
|
|
|
113 |
|
|
|
108 |
|
||||
Amortization of intangibles |
|
|
50 |
|
|
|
129 |
|
|
|
160 |
|
|
|
247 |
|
||||
Other income adjustment |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,350 |
) |
||||
Provision for income taxes |
|
|
15 |
|
|
|
10 |
|
|
|
13 |
|
|
|
27 |
|
||||
Non-GAAP Adjusted EBITDA |
|
$ |
(2,660 |
) |
|
$ |
(710 |
) |
|
$ |
(4,367 |
) |
|
$ |
(2,389 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20240815414420/en/
Investor Relations Contact:
385-426-0565
investor_relations@clearone.com
http://investors.clearone.com
Source: